pharmaphorum2h
Ten years on, Roche jettisons InterMune and Esbriet in US
Roche's sale of InterMune and Esbriet in the US comes as Boehringer revealed its own follow-up play in the IPF, category, ...
pharmaphorum6d
FDA expands label for Roche's eye disease implant Susvimo
The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...
Business Insider11d
Roche Holdings Inc.DL-Notes 2021(21/28) Reg.S Bond
The Roche Holdings Inc.-Bond was issued on the 12/13/2021 with a volume of 2 B. USD. Indices Commodities Currencies Stocks ...
PharmiWeb6d
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...